期刊文献+

基于随访的宫颈癌预后多因素生存分析 被引量:10

Multivariate survival analysis of prognostic factors for cervical cancer based on follow-up
下载PDF
导出
摘要 目的调查宫颈癌患者预后生存情况,找出实际医疗环境中影响宫颈癌预后的多种综合因素。方法对纳入研究的病例进行临床资料的收集和随访。采用COX回归模型分别对临床因素、病理因素、自身因素、社会经济因素进行分析。结果共纳入研究对象2 306例,最长随访时间为40个月,中位随访时间为14个月。三年生存率分别为91%、85%、78%。最终纳入COX回归模型的因素有宫旁侵犯程度、脉管癌栓、淋巴结转移、体重减轻、糖尿病史和职业收入。结论临床分期、治疗方案、脉管癌栓等被纳入模型的因素均可能影响宫颈癌患者的预后。 Objective To investigate the living conditions and quality of life of patients with cervical cancer after discharge, and find out the influence of various factors on the prognosis of cervical cancer in the actual medical environment. Methods Clinical data of the patients which were included in the study were collected and followed up. COX regression models were used to analyze the clinical factors, pathological factors, self factors, social and economic fac- tors. Results A total of 2 306 patients was included, the longest follow-up period was 40 months, and the median follow-up was 14 months. The three-year survival rates were 91%, 85% , 78%. Finally, factors included in the COX regression model were parametrial invasion, vascular invasion, lymph node metastasis, weight loss, diabetes and occupation income. Conclusion Clinical stage, treatment options, vascular tumor thrombus and other factors that may affect the prognosis of patients with cervical cancer.
出处 《哈尔滨医科大学学报》 CAS 2017年第1期83-86,共4页 Journal of Harbin Medical University
基金 国家自然科学基金资助项目(81202154 81372938)
关键词 宫颈癌 随访 生存率 多因素分析 cervical cancer follow-up survival rate multivariate analysis
  • 相关文献

参考文献3

二级参考文献64

  • 1刘冬娥.女性围绝经期的生理和病理变化[J].中国实用妇科与产科杂志,2004,20(8):473-474. 被引量:248
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3Perlroth DJ,Goldman DP, Garber AM. The potential impact ofcomparative effectiveness research on U.S. health careexpenditures. Demography, 2010,47 Suppl :S173-190.
  • 4Editorial. Comparative effectiveness research in the USA. Lancet,2009,373(9665):694.
  • 5Institute of Medicine (IOM). Initial National Priorities forComparative Effectiveness Research. Washington DC: Instituteof Medicine, 2009. Available at http://www.iom.edu/Reports/2009/Comparative Effectiveness Research Priorities.aspx.
  • 6Sox HC, Greenfield S. Comparative effectiveness research: areport from the Institute of Medicine. Ann Intern Med,2009,151(3):203-205.
  • 7Slutsky JR, Clancy CM. AHRQ' s Effective Health Care Program:why comparative effectiveness matters. Am J Med Qual,2009,24(1):67-70.
  • 8Godwin M, Ruhland L, Casson I,et al. Pragmatic controlledclinical trials in primary care : the struggle between external andinternal validity. BMC Med Res Methodol,2003,22(3) :28.
  • 9Morton SC, Ellenberg JH. Infusion of statistical science incomparative effectiveness research. Clin Trials,2012,9( 1):6-12.
  • 10Avom J. Debate about funding comparative-effectiveness research.N Engl J Med,2009,360(19):1927-1929.

共引文献112

同被引文献87

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部